US5674863A
(en)
*
|
1991-10-18 |
1997-10-07 |
Genentech, Inc. |
Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
|
CA2104371A1
(en)
*
|
1991-12-26 |
1993-06-27 |
Tohru Nakao |
Condensed thiophene compound and pharmaceutical use thereof
|
US5532240A
(en)
*
|
1991-12-26 |
1996-07-02 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Condensed thiophene compound and pharmaceutical use thereof
|
US6096763A
(en)
*
|
1995-02-23 |
2000-08-01 |
Merck & Co., Inc. |
α1a adrenergic receptor antagonists
|
US5952351A
(en)
*
|
1995-02-23 |
1999-09-14 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
US7125866B1
(en)
*
|
1999-04-30 |
2006-10-24 |
Regents Of The University Of Michigan |
Therapeutic applications of pro-apoptotic benzodiazepines
|
US6699885B2
(en)
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
IL122072A
(en)
|
1996-11-14 |
2001-03-19 |
Akzo Nobel Nv |
Piperidine derivatives their preparation and pharmaceutical compositions containing them
|
US7572788B2
(en)
*
|
1999-04-30 |
2009-08-11 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US20050113460A1
(en)
*
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US20060025388A1
(en)
|
1999-04-30 |
2006-02-02 |
Glick Gary D |
Compositions and methods relating to novel compounds and targets thereof
|
US20040176358A1
(en)
*
|
1999-04-30 |
2004-09-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
RU2257384C2
(ru)
*
|
2000-02-29 |
2005-07-27 |
Мицубиси Фарма Корпорейшн |
Новые производные циклического амида
|
UA73981C2
(en)
|
2000-03-10 |
2005-10-17 |
Merck Patent Gmbh |
(r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
|
KR20030065511A
(ko)
*
|
2000-11-14 |
2003-08-06 |
메르크 파텐트 게엠베하 |
조합된 선택적 도파민 d2 수용체 길항제 및 5-ht1a수용체 작용제의 신규한 용도
|
EP1408964B1
(de)
|
2001-07-26 |
2007-01-24 |
MERCK PATENT GmbH |
Verwendung von 2- 5-(4-fluorphenyl)-3-pyridylmethylaminomethyl-chroman und seiner physiologisch annehmbaren salze
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20050272723A1
(en)
*
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20060052369A1
(en)
*
|
2004-09-07 |
2006-03-09 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US7638624B2
(en)
*
|
2005-01-03 |
2009-12-29 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel benzodiazepine compounds and derivatives
|
US20070043033A1
(en)
|
2005-06-01 |
2007-02-22 |
The Regents Of The University Of Michigan |
Unsolvated benzodiazepine compositions and methods
|
US20070105844A1
(en)
*
|
2005-10-26 |
2007-05-10 |
Regents Of The University Of Michigan |
Therapeutic compositions and methods
|
EP2604269B1
(de)
|
2005-11-01 |
2014-09-24 |
The Regents Of The University Of Michigan |
1,4-Benzodiazepin-2,5-Dione mit therapeutischen Eigenschaften
|
WO2007110868A2
(en)
|
2006-03-28 |
2007-10-04 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
WO2008117269A2
(en)
*
|
2007-03-28 |
2008-10-02 |
Atir Holding S.A. |
Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
|
US7759338B2
(en)
*
|
2006-04-27 |
2010-07-20 |
The Regents Of The University Of Michigan |
Soluble 1,4 benzodiazepine compounds and stable salts thereof
|
NZ573452A
(en)
|
2006-06-09 |
2011-09-30 |
Univ Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
NZ579507A
(en)
|
2007-03-09 |
2011-11-25 |
Univ Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
AU2008298870C1
(en)
|
2007-09-14 |
2014-10-09 |
The Regents Of The University Of Michigan |
F1F0-ATPase inhibitors and related methods
|
CN101918375A
(zh)
|
2007-11-06 |
2010-12-15 |
密歇根大学董事会 |
在皮肤病症的治疗中有用的苯并二氮杂*酮化合物
|
US8497307B2
(en)
|
2008-09-11 |
2013-07-30 |
The Regents Of The University Of Michigan |
Aryl guanidine F1F0-ATPase inhibitors and related methods
|
WO2010121164A2
(en)
|
2009-04-17 |
2010-10-21 |
The Regents Of The University Of Michigan |
1,4-benzodiazepinone compounds and their use in treating cancer
|
EP2470020A4
(de)
|
2009-09-18 |
2013-03-13 |
Univ Michigan |
Benzodiazepinonverbindungen und behandlungsverfahren damit
|
JP5856063B2
(ja)
|
2009-11-17 |
2016-02-09 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
治療特性を有する1,4−ベンゾジアゼピン−2,5−ジオンおよび関連化合物
|
CN102753544A
(zh)
|
2009-11-17 |
2012-10-24 |
密执安大学评议会 |
具有治疗性能的1,4-苯并二氮杂*-2,5-二酮和相关化合物
|
EP3581567A1
(de)
|
2011-04-10 |
2019-12-18 |
Atir Holding S.A. |
Heterocyclische verbindungen und ihre verwendung bei der behandlung von sexuellen funktionsstörungen
|
EP3495363B1
(de)
|
2016-07-28 |
2023-08-23 |
Shionogi & Co., Ltd |
Stickstoffhaltige kondensierte ringverbindungen mit antagonistischer dopamin-d3-rezeptor-wirkung
|
WO2019146740A1
(ja)
|
2018-01-26 |
2019-08-01 |
塩野義製薬株式会社 |
ドーパミンd3受容体拮抗作用を有する環式化合物
|
CN111801330B
(zh)
|
2018-01-26 |
2024-04-05 |
盐野义制药株式会社 |
具有多巴胺d3受体拮抗作用的稠环化合物
|
US10745401B2
(en)
|
2018-07-23 |
2020-08-18 |
Sumitomo Dainippon Pharma Co., Ltd. |
Condensed lactam derivative
|
US11466007B2
(en)
*
|
2018-07-23 |
2022-10-11 |
Sumitomo Pharma Co., Ltd. |
Substituted lactams showing serotonin 5-HT receptor activity
|